Cramer's Morning Take: Adobe & Oracle 9/15/23

SPEAKER_1 (0:00)

Okay, text from the wedding planner.

SPEAKER_2 (0:02)

She's talking about a cake pop mural.

SPEAKER_1 (0:05)

Ah, exciting.

SPEAKER_2 (0:07)

Ooh, it's $8,000. Oh, I don't know, we're trying to save for a house.

SPEAKER_3 (0:12)

Well, you only get married once, or twice.

SPEAKER_1 (0:15)

The three time stops.

SPEAKER_3 (0:16)

There's a lot of bad money advice out there. For knowledge you can trust, come to GISA Credit Union. Whether it's saving for the wedding or everything that comes after, we can help get you where you wanna be.

Find a healthier approach to money at GISA.

Jim Cramer (0:33)

Hey, it's Cramer, and this is my morning take on the market from today's CNBC Investing Club morning meeting. Let's use this moment to talk about how the market's had a really good move, and there's just general selling, and not for any particular reason other than what a run.

Jeff Marks (0:48)

Yeah, sure. We're also seeing some tech stocks fall, another sell the news of an AI beneficiary, Adobe, even though the quarter looked fine.

Jim Cramer (0:57)

You know, Adobe ran from, if we go back to the previous quarter, Adobe ran too much, then it spent some time in the wilderness, and then you had to buy it. Now, we are not, we don't own Adobe, we do own Broadcom, which is viewed as a similar stock, and obviously, we have Nvidia. I didn't see anything in Adobe that just says that it's a peak AI.

The opposite, actually.

Jeff Marks (1:20)

Well, if you look at also Oracle this week, right, Oracle falls Tuesday, was trading around an all-time high into earnings, holds back, and now it's climbed back. It's got about a quarter of the losses it's recovered.

Jim Cramer (1:32)

Well, what did you think of that partnership?

Jeff Marks (1:33)

Yeah, well, look, so they announced a partnership today with Microsoft, everyone's calling it a win-win, it's a new partnership, it brings the Oracle database services on Oracle Cloud Infrastructure to Azure.

Jim Cramer (1:46)

I wonder where the site is coming to Oracle Cloud World. The big celebration.

Jeff Marks (1:52)

Next week.

Jim Cramer (1:52)

You know, SoftwareCats and I don't think people know who Larry Ellison was from the old days, but Larry, whom by the way Mark Benny often worked for, was the inventor of all this kind of software. And I know that a lot of people feel that Oracle's a problem because we know that people turn on Oracle after one quarter, but Oracle's had a history of having a quarter reset and we got that. I just didn't think it was gonna be this quarter, frankly.

Jeff Marks (2:15)

Yeah, right, and of course there's a lot of hot money in there as well, which exaggerates the move.

Jim Cramer (2:20)

We have to deal with the fact that it was up 50% going in. Stocks are up 50 or Adobe was up 60 Those are not stable because people are looking for reason and they find reasons. And Oracle, by the way, I have a lot of friends behind the scenes there at the top. They were pulled at how things went.

Start your day with my out look on the market every morning. Visit cnbc.com/morningtake to become a CNBC Investing Club member at a special rate today.

SPEAKER_2 (2:51)

All opinions expressed by Jim Cramer on this podcast and in connection with the CNBC Investing Club are solely Cramer's opinions and do not reflect the opinions of CNBC, NBC Universal, or their parent company or affiliates and may have been previously disseminated by Cramer on television, radio, internet, or another medium.

No specific outcome or profit is guaranteed in connection with your reliance upon or other use of the content from Cramer.

The opinions offered in connection with this podcast and the CNBC Investing Club are not an attempt to induce any particular trading behavior, investment, or strategy. You should be aware of the risk of loss in following any strategy or investment discussed in the content from Cramer. To view the full CNBC Investing Club Disclaimer, please visit cnbc.com forward slash investing club disclaimer.

SPEAKER_1 (3:34)

With sootic two for moderate to severe plaques psoriasis, you could show off your skin again. And you know what that means?

As a tick to inhibitor, sootic two is the only once daily pill of its kind for adults with moderate to severe plaques psoriasis. Ask your dermatologist about sootic two today and learn more at soclearlyyou.com. That's soclearlyyou.com.

Sootic two, decravicitinib, is a prescription treatment for adults with moderate to severe plaques psoriasis who may benefit from systemic therapy or phototherapy. Don't take if you're allergic to sootic two, serious reactions can occur. Before treatment, get checked for infections including tuberculosis. Sootic two can lower your ability to fight infections. Don't start if you have one. Serious infections, cancers including lymphoma, muscle problems and changes in certain labs have occurred. Tell your doctor if you have a history of these events or if you have an infection or symptoms like fever, sweats, chills, muscle aches or cough. Or if you have history of hepatitis B or C, liver or kidney problems, high triglycerides or had a vaccine or planned to. Sootic two inhibits tick two, which is part of the Jack family. People 50 and older with heart disease risk factors who use a Jack inhibitor are at increased risk for certain side effects, sometimes fatal. It's unknown if sootic two has the same risks as Jack inhibitors.